A newer JAMA Ophthalmology studyone of the first to compare semaglutide to other GLP-1 agonistsconfirmatively suggests that semaglutide carries a higher NAION risk than its peers, although details remain under peer review
People using semaglutide often juggle tradeoffs: the medications appetite and weight effects help many with reflux driven by obesity, yet the drugs direct impact on gastric emptying can produce new reflux for others
The metabolic therapeutics field will be shaped significantly by whether retatrutide's Phase 3 results validate its Phase 2 promise, potentially establishing triple agonism as the next evolution beyond semaglutide's proven single-agonist approach
Supporting GLP-1 Naturally Through the Microbiome GLP-1 is often discussed as a hormone that can be increased through medication, but emerging research shows that it is also deeply influenced by the gut microbiome
to recover from fatigue, menstrual pain and irregular menstruation
If you're curious about the benefits of L-Carnitine, its uses, and how it can support your health and fitness goals, continue reading to explore this essential amino acid